Hi Robin
This is a very interesting thread.
I know that the charity Cancer Research UK was doing a trial paralleling HERA to see if it could match the tumour characteristics of HERA participants with outcomes. I would imagine that they would be looking at the kinds of things that you have mentioned. It would be great if they could find out who doesn't respond because then they might be able to find out how to get the recurrence rate down even further.
My oncologist felt that Finher was significant, but needed more followup.
|